Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|September 25, 2020
Syndecan-4 as a Marker of Endothelial Dysfunction in Patients with Resistant HypertensionMark Lipphardt, Hassan Dihazi, Jens-Holger Maas, et al.
Journal of Neurochemistry|February 10, 2026
Intrathecal Kappa Free Light Chains in Relation to IgM Synthesis and MRZH Reaction in a Mixed Neurological CohortKristina Auf dem Brinke, Noah Benedict Thust, Amina Simou, et al.
Journal of Hypertension|May 4, 2016
Baroreflex activation therapy in patients with prior renal denervationManuel Wallbach, Marcel Halbach, Hannes Reuter, et al.
Journal of the American Heart Association|November 27, 2024
Urinary Dickkopf-3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart FailureDennis Pieper, Anja Sandek, Ann-Kathrin Schäfer, et al.
ESC Heart Failure|September 22, 2025
Finerenone in diabetic chronic kidney disease-Real-world insights including patients with HFpEF or HFmrEFKristian Hellenkamp, Sophia Kaebe, Miroslava Valentova, et al.
International Urology and Nephrology|July 16, 2021
Cystatin C predicts renal function impairment after partial or radical tumor nephrectomyMike Wenzel, Hang Yu, Annemarie Uhlig, et al.
Blood Purification|June 30, 2016
FABP1 and FABP3 Have High Predictive Values for Renal Replacement Therapy in Patients with Acute Kidney InjuryHassan Dihazi, Michael J Koziolek, Rabi R Datta, et al.
Journal of Clinical Medicine Research|June 15, 2017
Variables to Predict Nephrological Disease in General, and Glomerulonephritis in Particular, in Patients With MicrohematuriaCarsten Paul Bramlage, Manuel Wallbach, David Ellenberger, et al.
Pageof 5